At the Prevexxion RN launch event held in Istanbul by Boehringer Ingelheim, Aviagen TMENA Regional Technical Operations Manager Murat Yakar delivered a data-driven presentation titled “Critical Points in Ross Breeder Production in the Light of Genetic Progress.”

Speaking to an audience of breeder and layer professionals, Yakar highlighted the dramatic global shift in poultry meat production, noting that output has increased 15-fold from 1960 to 2020, with forecasts pointing to over 50% additional growth by 2050. According to Yakar, this expansion is not only fueled by genetic advancement but also by structured management systems, strong field implementation, and continuous professional development.

Yakar emphasized Aviagen’s strategic investment approach, stating that the company has allocated more than 10% of its annual turnover to R&D. And 2017 and 2024, this investment surpassed USD 170 million, strengthening farm infrastructure, hatchery capacity, processing facilities and genomic laboratories. “These investments aim to express genetic potential as efficiently as possible to improve production profitability,” he noted.

Performance data from the TMENA region between 2020 and 2025 demonstrated consistent breeder progress. Still, Yakar stressed that sustainable performance requires more than superior genetics. Weekly monitoring of parameters such as body weight, skeletal development, feathering and immune profile is essential for maintaining optimal condition in both females and males.

He particularly underlined the importance of individual male bodyweight profiles, which directly influence fertility and chick quality. Alongside monitoring, standardised biosecurity and continuous training of field teams remain essential to strengthening production’s weakest links.

Yakar concluded with a strategic message:

“Genetic superiority alone is not enough; sustainable profitability comes when management, health, nutrition, training and data analysis are evaluated together.”